In this task, you are given news articles and you need to generate a highlight, i.e., a short summary, with a maximum length of 10 lines.

Input: Consider Input: (CNN) -- Cristiano Ronaldo has urged his Real Madrid teammates to carry their recent impressive form into the New Year after they cut Barcelona's lead at the top of Spain's La Liga to two points. The Portugal international scored a spectacular goal as Real kept the pressure up on defending champions Barca with an emphatic 6-0 victory over Real Zaragoza. But Ronaldo does not want his colleagues to take their foot of the gas and keep the pressure on the Catalan side, who won the Club World Cup in Abu Dhabi, when the season resumes again on January 2 after the winter break. "It was important to seal the year with a victory, so we are happy about that. We must all now think of the New Year, which we should start as well as we've ended this one," Ronaldo told the club's Web site. "I'm working well and I want to carry on this way until the end of the season. I'm doing better every day. I missed two months and coming back was difficult, but things are working out for me." Real coach Manuel Pellegrini also paid tribute to Barcelona for an amazing 12 months in which they added the Club World Cup trophy to victory in La Liga, the Copa del Rey, Champions League and European and Spanish Super Cup titles. "What Barcelona have achieved is a great feat and hard to emulate. But there is also great merit in just being two points behind them on the table," he said. "We've played well away from home against the teams that earned the most points last year. Barcelona's excellent performances add to our own merit." Meanwhile, Hugo Sanchez become the fourth La Liga manager to lose his job his season after he was sacked by Almeria following their 2-0 away defeat to Espanyol which left them a point above the relegation zone. Almeria had lost eight of their 15 games in La Liga this season and the Mexican has been replaced by Constantin Galca, the coach of Almeria's B team, on a temporary basis.

Output: Cristiano Ronaldo has urged his Real Madrid teammates to carry their recent impressive form into the New Year .
Real Madrid cut the lead of defending champions Barcelona to two points after a 6-0 thrashing of Real Zaragoza.
Coach Manuel Pellegrini also paid tribute to Barcelona's amazing 12 months following their victory in the Club World Cup .


Input: Consider Input: Gaza City (CNN) -- With the latest failed cease-fire quickly becoming a distant memory, the two sides in the Israel-Gaza conflict traded rockets and airstrikes Saturday -- as well as blame for not stopping the bloodshed. Israeli airstrikes killed at least five more people in Gaza on Saturday, the official Palestinian news agency WAFA reported. The area around central Gaza's Qassam mosque, in particular, was a frenzy of activity as medical workers sifted through rubble there. WAFA claimed that Israeli fighter jets struck that mosque and another, killing at least three people. Less than a mile away from the Qassam mosque, a strike killed two men riding on a motorbike, Palestinian Health Ministry spokesman Dr. Ashraf el-Qedra said. Israel's military confirmed the strike, saying the two men were militants. El-Qedra added Saturday night that a 13-year-old girl died in an airstrike on her family home in Rafah. That was in addition to a 10-year-old boy who died while playing with friends, the Palestinian health ministry said. Then again, Israel is on the defensive as well. The Israel Defense Forces said that, since the end of the cease-fire early Friday, about 100 rockets were fired toward Israel from Gaza. That figure includes at least 30 launched Saturday, of which 24 hit Israel, the military said. The IDF responded by targeting "some 120 terror sites and nine terror operatives." All this back-and-forth, of course, is nothing new. The Israelis and Palestinians -- particularly Hamas, the Islamic militant group and political party that controls Gaza -- have been at it for weeks, with the former fending off persistent rocket attacks and the latter dealing with relentless Israeli strikes. There have been efforts to halt the bloodshed as well as to broach some of the thorny issues related to it. And there have been some breakthroughs, including a few cease-fires. Yet none of those peacemaking attempts, so far, has stuck. Death toll's rise slows . The death toll's climb has slowed since IDF announced overnight into Saturday an end of its ground incursion in Gaza -- even as it continued to strike from the air. Israeli forces say troops redeployed after completed their mission of destroying Hamas' tunnels. Still, while there weren't scores of dead Saturday as has been true many other days over the past few weeks, the total carnage remains significant. According to el-Qedra, at least 1,911 in Gaza have died since the conflict began, in addition to just under 10,000 injured. It's unclear how many casualties were militants: The United Nations estimates that about 70% of the dead were civilians, or about 1,340. IDF, meanwhile says about 900 militants have been killed, which would put the civilian death toll at around 1,000. IDF spokesman Lt. Col. Peter Lerner said that that number was a preliminary estimate based on field reports from troops returning from battle. Israeli officials say 64 Israeli soldiers have died, and three civilians were killed in Israel. The Iron Dome missile defense system has intercepted many of the rockets Gazan militants have fired at populated areas of the country. Blame game continues . Besides the violence, another thing that hasn't stopped is the blame game. One point of contention: who broke the most recent cease-fire hours before it was supposed to run out? Hamas denied firing rockets into Israel on Friday. Yet militants from Islamic Jihad and the Al-Nasser Salah al-Din Brigades admitted to doing just that -- blaming Israel for refusing to accept their demands during negotiations. Israeli government spokesman Mark Regev said it was Hamas' fault regardless, telling CNN the group runs Gaza and "can't outsource terrorism to the other groups. When they want to enforce a cease-fire, they do it very well." Hamas has been in charge of the Palestinian government in Gaza for years, while the Palestinian faction Fatah runs the government in the West Bank. The two groups have been at odds but also made repeated efforts at a unity government, including one earlier this year. One sad irony of all this bloodshed is that -- according to the Egyptian foreign ministry, which brokered recent talks -- the parties have reached an agreement on most issues. Those not agreed upon were few and limited, the ministry said in a statement. Still, there's too much history to show that agreement on some issues will not necessarily lead to a grander breakthrough. The Palestinians have asked for Israel to lift its blockade on Gaza and to re-open the air and seaports, a Palestinian negotiation who spoke on condition of anonymity said. Israeli authorities fear Hamas could import weapons by sea and maintains a ship blockade off Gaza's shores. Palestinians also wanted Israel to extend Gaza's fishing zone in the Mediterranean from three miles off the coast to 20. Fishing is a keystone of Gazan livelihoods. But Israel was willing to extend fishing rights to only six miles off the coast, said Hamas spokesman Sami Abu Zuhri. Yet Israel is resisting in-depth talks as long as rockets continue to head toward its territory. After Gazan rocket fire on Friday, Israel's Foreign Ministry said the country "will not conduct negotiations while under fire." CNN exclusive: Inside the mind of Hamas' political leader . Nobel laureate Wiesel: Hamas must stop using children as human shields . Gaza conflict: Can economic isolation ever be reversed? Life in Gaza: Misery heightened by war . CNN's John Vause reported from Gaza, Matthew Chance reported from Jerusalem; Ben Brumfield and Greg Botelho wrote and reported from Atlanta. CNN's Jethro Mullen, Ali Younes, Tal Heinrich, Jake Tapper and Samira Said also contributed to this report.

Output: NEW: Palestinian official: 13-year-old girl killed by Israeli airstrike .
NEW: Israeli military: About 100 rockets from Gaza since cease-fire's end .
Israel and Hamas criticize one another for not doing more to halt violence .


Input: Consider Input: (CNN) -- Renee Mosier was one of an estimated half-million patients in the United States who were unable to get the drugs they needed because of shortages. "You feel like you're in a fight with one hand tied behind your back," said Mosier, 56. It was a fight she lost in June. According to the Food and Drug Administration, the number of drug shortages has increased nearly 300% since 2005. More than half of the drugs on the shortage list are considered critical -- meaning they have no alternative. The drugs most often in short supply include anesthetics and oncological drugs. Mosier was diagnosed in 2006 with ovarian cancer, the fifth-deadliest cancer for women, according to the American Cancer Society. Surgery and treatment were able to keep her tumors at bay until 2009, when she returned to surgery. She was back in remission until June 2011, when her cancer appeared once again. Mosier was able to get her required surgery, but her doctor, Dr. Wendel Naumann, was unable to get Doxil, the chemotherapy treatment she needed. 'A huge, growing crisis in this country' "This is a huge, growing crisis in this country, where we're actually having to ration drugs," said Naumann, who calls it "unbelievable." In November 2011, Mosier appeared on CNN's "Sanjay Gupta, MD" to share her ordeal. She told Dr. Sanjay Gupta, CNN's chief medical correspondent, that without Doxil, she had few alternatives. "At the time we just said, 'Let's go with what we have, and see what happens,' and the cancer pretty rapidly recurred." Mosier was never able to get another dose of Doxil and spent the last month of her life in hospice care. She was able to make one last trip -- to the Bahamas to attend her daughter's wedding. In a follow-up interview with Mosier's daughters on this past weekend's "Sanjay Gupta, MD," daughter Michelle Philipp told Gupta, "We weren't sure until even (the) last minute if she was able to come. So we bought her the ticket, hoping it would give her something for her to look forward to, and she did, and it was just wonderful." On June 29, 2012, Mosier died. Philipp's sister, Nicole Penninger, didn't hide her frustration with the situation. "You feel like you're in this time now, it's 2012. You feel like, you're in America. Why can't she get these drugs, that she needs to treat something so serious?" Critical dependence on a few companies . How did it get to this point? According to Naumann, "We only have a couple of companies, and the problem is that if one of these companies goes down because of FDA inspections, manufacturing problems or something like that, we don't have those drugs if only one company is making them." The House Oversight Committee came to the same conclusion. In a recent report, the panel claimed the FDA -- the very agency tasked with dealing with shortages -- is partly to blame for the shortage situation. The report paints a scathing picture of a regulatory agency that gave little consideration to the potential outcome of its actions. "The committee has learned that FDA regulatory activity has effectively shut down 30% of the total manufacturing capacity at four of America's largest producers of generic injectable medications," it said. "The FDA has failed to ensure that enforcement and compliance activities are conducted in a manner that does not create unnecessary shortages of critical drugs," according to the House report. That report is disputed by the FDA. "Let me just say, very clearly, that the report is incorrect," Dr. Sandra Kweder of the FDA said on "Sanjay Gupta, MD." "We are not in this situation because the FDA is shutting down companies. FDA is part of the solution." Kweder is the deputy director of the FDA's Center for Drug Evaluation and Research, Office of New Drugs. She said FDA inspection processes and enforcement rules have not changed. "What has changed is that there is an aging manufacturing infrastructure, and there are serious quality problems that have required companies to close down to fix the problems." On Monday, the FDA issued a letter to Rep. Elijah Cummings (D-Maryland) of the House Oversight Committee, responding to the committee's blaming the FDA for the shortages. The letter reiterated the report was false and emphasized the FDA is part of the solution. What happened with Doxil . While Doxil is not a generic drug, it was manufactured by Ben Venue Laboratories, one of the country's four largest producers of generic injectables. The Ben Venue lab was the sole manufacturer of Doxil in the nation. It voluntarily shut down in November 2011. A May 2011 FDA inspection found a string of problems, including inadequate oversight and metallic particle shards in some of the drugs produced on site. A November 2011 FDA inspection found additional problems, including finding a 10-gallon can in a storage area that contained urine. In a statement sent to CNN after it shut down, Ben Venue labs said its team "has been working around the clock to implement changes needed to ensure a more sustained supply of the medicines we produce and to address the manufacturing-related issues at our facility noted in recent inspections by the FDA and other global regulatory agencies." However, Ben Venue maintained that none of the Doxil supply was affected. From their findings, the House Oversight Committee found that 58% of the drugs on the shortage list were produced at facilities cited by the FDA. They also found that the FDA's warning letters increased 156% from 2010 to 2011. Dr. Scott Gottlieb, former FDA deputy commissioner, said the FDA isn't concerned about the outcome, though. "They go in, they inspect facilities and then they issue findings. You're not asked to worry if there's a stable supply. You're asked to make sure the facility falls in line." But Kweder says it's quite the opposite. "Well, it's our job to worry about it in our drug shortages team. When we issue warning letters today, we ask companies to very specifically communicate with us how they plan to address the problem, so we can assess what the potential of a shortage is, " she told CNN. Kweder also cited the recent reauthorization of the Prescription Drug User Fee Act as a key to preventing shortages. Signed by President Barack Obama earlier this month, the act will help the FDA expedite the drug review process, particularly for drugs in shortage. It will also require companies to notify the FDA if they anticipate an interruption in production. "It allows us as a regulatory agency to step in, and try and prevent the shortage in the first place," Kweder said. "So for example, we can go to other companies to ask them to increase their production. We can assist companies that are having difficulties to finding alternatives for the difficulties they are having, and even in rare cases, we can seek sources of medications from other countries, where they might be being produced to our standards." Help comes from abroad . That's actually what happened in the case of Doxil. In February, the FDA stepped in and allowed the importation of Lipodox from an Indian manufacturer, a possible therapeutic alternative. But Naumann said he was never able to get his hands on it. "The key is having enough notice," says Kweder. Since Obama signed an executive order requesting early notification from manufacturers in November 2011, more and more companies have been able to give the FDA the needed heads-up. "We've done that successfully innumerable times. Just since January, at our count, we've prevented 94 to 100 shortages, things the public never sees," Kweder told Gupta. "I think it's a start," says Naumann, but it's not enough. "I think these shortages are going to continue because of the same problems that we have. There are certainly fixes out there for it. I don't think these shortages are going to go away because of this bill." For Mosier's daughters, it's all too late. Had Mosier gotten the Doxil, Philipp says, "I think she thought it would have at least put her in remission in another time, or it would save her from the chemo that was detrimental to her."


Output: Renee Mosier, who had cancer, died after not receiving the drug she needed .
The number of drug shortages is up 300% since 2005, according to the FDA .
The House Oversight Committee blames the FDA for shortages .